Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

2 Résultats
authFullName_s : M. Flamant

Acceptability of treatment regimen in inflammatory bowel disease: Results from a prospective nationwide study (ACCEPT2)

A. Buisson , Mathurin Fumery , M. Serrero , L. Orsat , S. Nancey , et al.
2020, pp.S337-S338
Autre publication scientifique hal-03551532v1

Which second-line biologic after anti-TNF failure during Crohn's disease: Ustekinumab or vedolizumab, a multicentre retrospective study

C. Rayer , X. Roblin , D. Laharie , Benoît Caron , M. Flamant , et al.
Journal of Crohn's and Colitis, 2020, 14 (1), pp.S547. ⟨10.1093/ecco-jcc/jjz203.793⟩
Article dans une revue hal-03551537v1